Drugs
Psychoactives, nootropics, harm reduction, culture, and work.
How Psilocybin Works
Psilocybin, psilocin, 5-HT2A receptors, default-mode network disruption, therapeutic promise, psychological risk, and why insight still needs aftercare.
How Cocaine Works
Dopamine, norepinephrine, serotonin, sodium channels, status theater, cardiac risk, dependence, and why borrowed confidence always sends an invoice.
Cocaine Is a UI for Status
Coke is less interesting as rebellion than as interface: speed, confidence, money, risk, and the brutal crash after borrowed charisma.
GHB, Consent, and the Thin Margin
GHB sits at the brutal intersection of pleasure, risk, nightlife, consent, stigma, and the fantasy that adults can freestyle chemistry safely.
Mushrooms, Acid, and the Aftercare Problem
Psychedelic culture talks endlessly about breakthrough. The harder, less merch-friendly question is what you do with yourself on Tuesday.
Salvia Refuses Your Productivity Stack
Salvia is the anti-optimization drug: weird, humbling, short, and culturally useless to anyone trying to monetize transcendence.
Weed, Privacy, and the Group Chat
Cannabis got normalized faster than our privacy habits did. The plant may be legal-ish; the data trail is still a narc with a clipboard.
Nootropics for People Who Hate Productivity Cults
A skeptical field note on focus, ritual, caffeine, placebo, and the exhausting fantasy that every neuron should be monetized.
The Morning After the Quantified Self
Wearables promised self-knowledge. Sometimes they delivered a tiny wrist tribunal with charts.